Analysis of King's Score in Chronic Liver Diseases Based On Fibroscan

You might also like

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

Analysis of King's Score in Chronic Liver Diseases Based on Fibroscan

Wira1, Amaliyah T. Lopa1, Ibrahim Abdul Samad1


1
Department of Clinical Pathology Science, Medical Faculty, Hasanuddin university,
Makassar
Abstract
Chronic liver disease is a commonly found disease in Indonesia and remains a serious
health problem. Chronic liver disease often progresses to hepatic cirrhosis or hepatoma
initiated by fibrotic process in liver. Liver biopsy result is a gold standard in determining the
liver fibrosis degree, but its some limitations. King's Score is a noninvasive method that uses
routine laboratory predictors to predict liver fibrosis. Therefore, it is necessary to know the
extent to which King's Score is useful in determining the fibrosis degree of liver chronic
disease by using fibroscan as gold standard in place of biopsy. This study was a retrospective
study with data collected from medical records in Medical Record Installation of dr. Wahidin
Sudirohusodo general hospital from January 2011 to December 2013. Study results of 99
samples with Spearman correlation test showed a significant relationship between King's
Score and fibrosis degree of chronic liver disease (p=0.000 and r=0.651). Analysis of receiver
operating characteristics (ROC) indicated that in mild and moderate fibrosis the AUC value
was too weak, whereas in heavy fibrosis the AUC value was 0.860, statistically very strong
with cut-off value of 7.15 and with 80.6% sensitivity and 75.0% specificity. King's Score
value of >7.15 can be used as a heavy fibrosis degree predictor in chronic liver patients.
Further studies are needed to analyze King's Score based on chronic liver disease etiology
and use liver biopsy as gold standard in determining liver fibrosis degree.
Keywords: King's Score, chronic liver disease, liver fibrosis, fibroscan.

Correspondence address :
Wira
Phone : 085299695443
Email : wiranusarah@gmail.com

Analisis Kings Score Pada Penyakit Hati Kronik Berdasarkan Fibroscan

Wira1, Amaliyah T.Lopa1, Ibrahim Abdul Samad1


1
Departemen Ilmu Patologi Klinik, Fakultas Kedokteran, Universitas Hasanuddin, Makassar
Abstrak
Penyakit hati kronik merupakan penyakit yang sering dijumpai di Indonesia dan
masih menjadi masalah kesehatan yang serius. Penyakit hati kronik sering berlanjut sampai
pada sirosis hati atau hepatoma diawali dengan proses fibrosis pada hati. Hasil biopsi hati
merupakan baku emas penentuan derajat fibrosis hati tetapi memiliki beberapa keterbatasan.
Kings Score merupakan metode noninvasif dengan menggunakan petanda laboratorium
untuk memprediksi fibrosis hati. Untuk itu penting diketahui sejauh mana Kings Score
bermanfaat dalam menentukan derajat fibrosis penyakit hati kroniks dengan menggunakan
fibroscan sebagai baku emas pengganti biopsi. Penelitian ini dilakukan secara retrospektif
dengan mengambil data rekam medik di Instalasi Rekam Medik RSUP dr.Wahidin
Sudirohusodo Makassar periode Januari 2011- Desember 2013. Hasil penelitian didapatkan
99 sampel dengan hasil uji korelasi Spearman menunjukkan adanya hubungan bermakna
antara Kings Score dengan derajat fibrosis penyakit hati kronik (p=0.000 dan r =0.651).
Analisis Receiver Operating Characteristics (ROC) didapatkan pada fibrosis ringan dan
sedang memiliki nilai AUC sangat lemah sedangkan pada fibrosis berat nilai AUC 0.860
secara statistik sangat kuat dengan titik potong 7.15 dengan sensitivitas 80.6% dan
spesitifitas 75.0%. Nilai Kings Score > 7.15 dapat dijadikan petanda derajat fibrosis berat
pasien penyakit hati kronik. Penelitian selanjutnya diharapakan menganalisis Kings Score
berdasarkan etiologi penyakit hati kronik dan menggunakan biopsi hati sebagai baku emas
dalam penentuan derajat fibrosis hati.

Kata kunci : Kings Score, penyakit hati kronik, fibrosis hati, fibroscan.

You might also like